...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zacks
4
May 07, 2020 08:47AM

Oh no!

Hopefully not another TSX listing!!!!!!!

 

Share
New Message
Please login to post a reply